CAPECITAPINE TABS 500 MG

This tender, sourced from Jordan via joneps_jo, is for the procurement of Capecitabine Tablets 500 mg. This represents a pharmaceutical supply tender, likely issued by a national health ministry, hospital network, or a governmental procurement agency. Capecitabine is an oral chemotherapy prodrug that is converted to 5-fluorouracil (5-FU) in the body and is used in the treatment of metastatic breast and colorectal cancers. For this tender, bidders will be expected to supply tablets of the specified dosage (500 mg) and form. Key requirements will include adherence to international pharmaceutical quality standards, such as Good Manufacturing Practices (GMP), and the provision of comprehensive product documentation. This would typically encompass detailed chemical and physical specifications, batch analysis certificates, and evidence of product stability. Packaging must ensure product integrity and compliance with local regulatory requirements for pharmaceuticals, including appropriate labeling in Arabic and English. Suppliers are generally required to provide proof of manufacturing licenses, regulatory approvals, and a reliable supply chain to meet the anticipated demand. The evaluation criteria will likely focus on the quality and compliance of the offered product, the supplier's capacity and experience, and the overall cost-effectiveness of the bid.